| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |